Yu Xu

1.3k citations
70 papers · 984 indexed · 1 hit paper · h-index 19
Topics
Endometrial and Cervical Cancer Treatments (11 papers)Uterine Myomas and Treatments (8 papers)Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Yu Xu

64 papers receiving 973 citations

Hit Papers

Betulinic acid inhibits pyroptosis in spinal cord injury ...202120262022202420214080120

Peers

Yu Xu
Comparison fields: 5 of 106
  • Molecular Biology 376
  • Epidemiology 196
  • Surgery 150
  • Pathology and Forensic Medicine 133
  • Pulmonary and Respiratory Medicine 120
Replace Sibel Bektaş with:
Sibel Bektaş Türkiye
Timo Brandenburger Germany
Masatoshi Muraoka Japan
Serpil Erdoğan Türkiye
Adrian Doroszko Poland
Salvatore Arena Italy
T Maekawa Japan
Lili Xu China
Zhichun Feng China
Yanhua Chen China
Yu Xu relative to Sibel Bektaş Türkiye Sibel Bektaş's profile →
Citations per field
00.5×
Sibel Bektaş · 1×
Citations per year

Countries citing papers authored by Yu Xu

Since Specialization
Citations

This map shows the geographic impact of Yu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Xu more than expected).

Fields of papers citing papers by Yu Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Xu. The network helps show where Yu Xu may publish in the future.

Co-authorship network of co-authors of Yu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Xu. A scholar is included among the top collaborators of Yu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Xu. Yu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 2
5 2
6 18
7 3
8 7
9 0
10 4
11 8
12 17
13 27
14 6
15 11
16 2
17 8
18 2
19 29
20 54

About Yu Xu

Yu Xu is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Parasitology, having authored 70 papers that have together received 984 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (11 papers), Uterine Myomas and Treatments (8 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (42 citations), Pathology and Forensic Medicine (133 citations) and Cancer Research (107 citations). Yu Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Kailiang Zhou, Xinli Hu, Haojie Zhang, Yao Li, Xiangyang Wang, Hui Xu, Ying Han, Haiyang Tang, Shuo Sun and Aidong Chen. Their work appears in journals such as Journal of Clinical Oncology, Environmental Pollution and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026